Recovery Of Ocular Events With Longer-Term Follow-Up In The Dreamm-2 Study Of Single-Agent Belantamab Mafodotin In Patients With Relapsed Or Refractory Multiple Myeloma

BRITISH JOURNAL OF HAEMATOLOGY(2021)

引用 10|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要